Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
Eve
E
Courbon
François
F
Laylavoix
Cathia
C
Soulié
Christine
C
Le Beller
Vincent
V
Calvez
Christine
C
Katlama
Gilles
G
Peytavin
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000069446:Atazanavir Sulfate; D001660:Biliary Tract Diseases / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D020347:Lithiasis / Q000139:chemically induced* / Q000175:diagnosis* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000008:administration & dosage / Q000009:adverse effects*; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*
D019380:Anti-HIV Agents; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate